top of page
Executive Spotlights

Casma Therapeutics Announces CEO Transition

Cambridge, MA, January 31, 2023 (Business Wire) -- Casma Therapeutics, a biotechnology company engaging the autophagy system to provide innovative new medicines, today announced that Keith Dionne, Ph.D., has stepped down as Chief Executive Officer, effective January 13, 2023. Dr. Dionne will continue to serve on the Board of Directors. Frank Gentile, Ph.D., formerly Chief Operating Officer of Casma, has been appointed as the new Chief Executive Officer and will also serve on the Board of Directors.

Read full article here.

Recent Posts

See All
Life Science Headlines
bottom of page